Lisbeth Barkholt

4.9k total citations · 1 hit paper
82 papers, 3.8k citations indexed

About

Lisbeth Barkholt is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Lisbeth Barkholt has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 36 papers in Epidemiology and 27 papers in Oncology. Recurrent topics in Lisbeth Barkholt's work include Hematopoietic Stem Cell Transplantation (35 papers), Cytomegalovirus and herpesvirus research (27 papers) and Polyomavirus and related diseases (15 papers). Lisbeth Barkholt is often cited by papers focused on Hematopoietic Stem Cell Transplantation (35 papers), Cytomegalovirus and herpesvirus research (27 papers) and Polyomavirus and related diseases (15 papers). Lisbeth Barkholt collaborates with scholars based in Sweden, Italy and Germany. Lisbeth Barkholt's co-authors include Olle Ringdén, J Aschan, Mats Remberger, Mehmet Uzunel, Brigitta Omazic, Katarina Le Blanc, Zuzana Hassan, Berit Sundberg, Hanns–Ulrich Marschall and Aldona Dlugosz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Lisbeth Barkholt

80 papers receiving 3.7k citations

Hit Papers

Mesenchymal Stem Cells for Treatment of Therapy-Resistant... 2006 2026 2012 2019 2006 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
    2006 893 citations Olle Ringdén, Mehmet Uzunel et al. Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisbeth Barkholt Sweden 30 1.2k 1.1k 1.0k 917 711 82 3.8k
J Aschan Sweden 39 2.7k 2.2× 1.2k 1.1× 1.1k 1.0× 1.1k 1.2× 1.3k 1.8× 107 4.8k
Åke Öst Sweden 35 2.0k 1.6× 764 0.7× 772 0.7× 868 0.9× 977 1.4× 112 4.4k
Volker Witt Austria 21 1.0k 0.9× 434 0.4× 598 0.6× 523 0.6× 967 1.4× 61 3.4k
Je‐Hwan Lee South Korea 40 3.0k 2.5× 628 0.6× 821 0.8× 1.1k 1.2× 972 1.4× 309 5.0k
Naoyuki Katayama Japan 35 1.1k 0.9× 503 0.5× 428 0.4× 795 0.9× 1.2k 1.7× 246 3.9k
Renato Fanin Italy 42 3.6k 2.9× 665 0.6× 1.4k 1.4× 2.0k 2.2× 1.2k 1.7× 226 6.6k
Alessandro Busca Italy 30 1.1k 0.9× 880 0.8× 991 0.9× 814 0.9× 682 1.0× 152 4.0k
E. Donnall Thomas United States 35 3.1k 2.5× 794 0.7× 836 0.8× 1.1k 1.2× 1.4k 2.0× 93 5.3k
Takehiko Mori Japan 40 2.2k 1.8× 1.2k 1.1× 576 0.6× 1.3k 1.4× 879 1.2× 303 5.0k
David E. Yocum United States 33 790 0.7× 499 0.5× 399 0.4× 472 0.5× 1.3k 1.8× 89 4.8k

Countries citing papers authored by Lisbeth Barkholt

Since Specialization
Citations

This map shows the geographic impact of Lisbeth Barkholt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisbeth Barkholt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisbeth Barkholt more than expected).

Fields of papers citing papers by Lisbeth Barkholt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisbeth Barkholt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisbeth Barkholt. The network helps show where Lisbeth Barkholt may publish in the future.

Co-authorship network of co-authors of Lisbeth Barkholt

This figure shows the co-authorship network connecting the top 25 collaborators of Lisbeth Barkholt. A scholar is included among the top collaborators of Lisbeth Barkholt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisbeth Barkholt. Lisbeth Barkholt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barkholt, Lisbeth, et al.. (2018). European regulatory experience with advanced therapy medicinal products. Nature Reviews Drug Discovery. 18(1). 8–9. 23 indexed citations
2.
Crocchiolo, Roberto, Olle Ringdén, Didier Blaise, et al.. (2017). Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma. Bone Marrow Transplantation. 53(2). 213–218. 6 indexed citations
3.
Omazic, Brigitta, Mats Remberger, Lisbeth Barkholt, et al.. (2015). Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer. Biology of Blood and Marrow Transplantation. 22(4). 676–681. 8 indexed citations
4.
Barkholt, Lisbeth, Egbert Flory, Veronika Jekerle, et al.. (2013). Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints. Cytotherapy. 15(7). 753–759. 317 indexed citations
5.
Hebart, Holger, Claudia Lengerke, Per Ljungman, et al.. (2010). Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT. Bone Marrow Transplantation. 46(3). 408–415. 16 indexed citations
6.
Demirer, Taner, Lisbeth Barkholt, Didier Blaise, et al.. (2008). Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. Nature Clinical Practice Oncology. 5(5). 256–267. 63 indexed citations
7.
8.
Barkholt, Lisbeth, Marco Bregni, Mats Remberger, et al.. (2006). Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Annals of Oncology. 17(7). 1134–1140. 58 indexed citations
9.
Barkholt, Lisbeth, Annika Linde, & Kerstin I. Falk. (2005). OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation. Transplant International. 18(7). 835–843. 9 indexed citations
10.
Hentschke, P, Jonas Mattsson, Inger Lundkvist, et al.. (2005). T‐Cell Receptor Vβ Repertoire after Myeloablative and Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation. Scandinavian Journal of Immunology. 61(3). 285–294. 12 indexed citations
11.
Helldén, Anders, Ingegerd Odar‐Cederlöf, Lisbeth Barkholt, et al.. (2003). High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrology Dialysis Transplantation. 18(6). 1135–1141. 76 indexed citations
12.
Ljungman, Per, Gunilla Kumlien, J Aschan, et al.. (2002). Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors. Scandinavian Journal of Infectious Diseases. 34(5). 347–350. 42 indexed citations
13.
Remberger, Mats, Jonas Mattsson, P Hentschke, et al.. (2002). The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors. Bone Marrow Transplantation. 30(11). 761–768. 16 indexed citations
14.
Mattsson, Jonas, Mehmet Uzunel, Mats Brune, et al.. (2001). Mixed chimaerism is common at the time of acute graft‐versus‐host disease and disease response in patients receiving non‐myeloablative conditioning and allogeneic stem cell transplantation. British Journal of Haematology. 115(4). 935–944. 51 indexed citations
15.
Remberger, Mats, J Aschan, Lisbeth Barkholt, J Tollemar, & Olle Ringdén. (2001). Treatment of severe acute graft‐versus‐host disease with anti‐thymocyte globulin. Clinical Transplantation. 15(3). 147–153. 62 indexed citations
16.
Barkholt, Lisbeth, Catharina Hultgren, Yukio Ando, et al.. (1999). Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products. Gut. 44(2). 274–278. 7 indexed citations
17.
18.
Yun, Zhibing, et al.. (1997). DYNAMIC ANALYSIS OF HEPATITIS C VIRUS POLYMORPHISM IN PATIENTS WITH ORTHOTOPIC LIVER TRANSPLANTATION. Transplantation. 64(1). 170–172. 16 indexed citations
19.
Svensson, Jan‐Olof, Lisbeth Barkholt, & Juliette Säwe. (1997). Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 690(1-2). 363–366. 44 indexed citations
20.
Barkholt, Lisbeth, Bo‐Göran Ericzon, J Tollemar, et al.. (1993). Infections in human liver recipients: different patterns early and late after transplantation. Transplant International. 6(2). 77–84. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Aschan Breakdown of academic impact, for papers by Åke Öst Breakdown of academic impact, for papers by Volker Witt Breakdown of academic impact, for papers by Je‐Hwan Lee Breakdown of academic impact, for papers by Naoyuki Katayama Breakdown of academic impact, for papers by Renato Fanin Breakdown of academic impact, for papers by Alessandro Busca Breakdown of academic impact, for papers by E. Donnall Thomas Breakdown of academic impact, for papers by Takehiko Mori Breakdown of academic impact, for papers by David E. Yocum
Rankless by CCL
2026